Cargando…
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study
INTRODUCTION: Treatment-refractory, acute graft-versus-host disease (GvHD) of the lower gastrointestinal tract (GI) after allogeneic hematopoietic stem cell transplantation is life threatening and lacks effective treatment options. While fecal microbiota transplantation (FMT) was shown to ameliorate...
Autores principales: | Spindelboeck, Walter, Halwachs, Bettina, Bayer, Nadine, Huber-Krassnitzer, Bianca, Schulz, Eduard, Uhl, Barbara, Gaksch, Lukas, Hatzl, Stefan, Bachmayr, Victoria, Kleissl, Lisa, Kump, Patrizia, Deutsch, Alexander, Stary, Georg, Greinix, Hildegard, Gorkiewicz, Gregor, Högenauer, Christoph, Neumeister, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721365/ https://www.ncbi.nlm.nih.gov/pubmed/34987741 http://dx.doi.org/10.1177/20406207211058333 |
Ejemplares similares
-
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
por: Bojanic, Ines, et al.
Publicado: (2023) -
Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015) -
Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022) -
Antibody- and aptamer-strategies for GvHD prevention
por: Oelkrug, Christopher, et al.
Publicado: (2015) -
Established and Emerging Treatments of Skin GvHD
por: Link-Rachner, Cornelia S., et al.
Publicado: (2022)